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a b s t r a c t
Ethnopharmacological relevance: Traditional Mongolian medicine (TMM) uses preparations from herbs as
one form of medication for the treatment of a diversity of diseases including diabetes mellitus (DM). We
evaluated the effect of extracts from the plant Leonurus sibiricus L. (LS), used in TMM to treat typical
symptoms of type 2 DM, on insulin secretion, electrophysiological properties, intracellular calcium
concentration and cell proliferation of INS-1E insulinoma cells under standard cell culture conditions
(SCC; 11.1 mM glucose).
Materials and methods: Insulin secretion was measured by ELISA, electrical properties were assessed by
whole cell patch clamping, intracellular calcium concentration (Cai) by Fluo-4 time lapse imaging, insulin
receptor expression was veriﬁed by RT-PCR and cell proliferation assessed by CellTiter-Glos cell
viability assay.
Results: Insulin released from INS-1E cells into the culture medium over 24 h was signiﬁcantly increased
in presence of 500 mg/L aqueous LS extract (LS OWE) as well as methanolic LS extract (LS MeOH/H2O)
but not in the presence of the butanol-soluble extract (LS MeOH/BuOH). Acute application of LS OWE
resulted in a depolarization of the cell membrane potential paralleled by an initial increase and
subsequent decline and silencing of action potential frequency, by KATP channel inhibition, persisting
depolarization and an increase in Cai. The electrophysiological effects were comparable to those of
100 μM tolbutamide, which, however failed to elevate insulin secretion under SCC. Furthermore all LS
extracts stimulated INS-1E cell proliferation.
Conclusions: The ﬁnding that extracts from Leonurus sibiricus L. enhance insulin secretion and/or foster
cell proliferation may provide possible explanations for the underlying therapeutic principles in the
empirical use of LS-containing formulations in DM and DM-related disorders as applied in TMM.
& 2013 The Authors. Published by Elsevier Ireland Ltd.
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/jep
Journal of Ethnopharmacology
http://dx.doi.org/10.1016/j.jep.2013.08.013
0378-8741 & 2013 The Authors. Published by Elsevier Ireland Ltd.
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Abbreviations: AP, action potential; Cai, intracellular calcium concentration; DM, Diabetes mellitus; T2DM, type 2 diabetes mellitus; DMrD, DM-related disorders; GLUT-4,
glucose transporter isoform 4; IKATP, ATP-sensitive Kþ conductance/currents; IR, insulin receptor; LS, Leonurus sibiricus L.; LSMeOH/BuOH, Leonurus sibiricus puriﬁed
methanolic extract; LS MeOH/H2O, Leonurus sibiricus water-soluble part of the methanolic extract; LS OWE, Leonurus sibiricus original water extract; SCC, standard cell
culture condition; T2DM, Type 2 Diabetes mellitus; TMM, Traditional Mongolian Medicine; TOL, tolbutamide; Vmem, cell membrane potential; WHO, World Health
Organization.
n Correspondence to: Institute of Physiology and Pathophysiology, Paracelsus Medical University Salzburg, Strubergasse 21, 5020 Salzburg, Austria. Tel.: þ43 662 442002
1250; fax: þ43 662 442002 1259.
E-mail addresses: sabine.schmidt@pmu.ac.at, schmidtsabine@gmx.at (S. Schmidt), markus.ritter@pmu.ac.at (M. Ritter).
1 Current address: Department of Dermatology, School of Medicine and Public Health, University of Wisconsin-Madison, WI, USA.
Journal of Ethnopharmacology 150 (2013) 85–94
Open access under CC BY-NC-ND license.
Open access under CC BY-NC-ND license.
1. Introduction
Driven by socio-economic needs empiricism-based traditional
healing methods have gained worldwide attention with respect to
evidence based scientiﬁc evaluation of their medical efﬁciency,
unraveling the mode(s) of action(s) as well as identiﬁcation of active
constituents. However, national pharmacopoeias or other regulations
regarding formulae, analytical composition, physical constants, main
chemical properties and mode(s) of preparation of traditional herbal
medicines do not exist in the majority of countries practicing
traditional medicines (WHO, 2005). Traditional Mongolian medicine
(TMM), using herbs as one form of medication, exists for more than
2500 years. 200–250 medicinal plants are commonly used and more
than 800 plants have been registered in Mongolia as medicinal
plants. TMM has developed from traditional Tibetan medicine by
replacing shamanistic practices with medical theories, techniques
and medications (Ligaa, 1996).
In the year 2010 worldwide approximately 285 million people
were affected by Diabetes mellitus (DM) with type 2 (T2DM)
making up about 90% of the cases (Melmed et al., 2011). The
incidence of T2DM is increasing rapidly (Wild et al., 2004), and the
disease is a major socio-economic cost factor for all health care
systems (WHO, 2013). Since antiquity, DM or DM-related disorders
(DMrD) have been treated with herbal medicines, such as plants
and their extracts. In Mongolia, different medicinal plants are used
in the treatment of DM or DMrD, such as the prescription BAIMAI-
SAN, which consists of 19 different ingredients (Liu et al., 2011).
However, to date, only a small number of scientiﬁc studies have
addressed the application of medicinal plants, traditionally used in
TMM, to treat DM and the underlying mechanisms of action still
have to be identiﬁed.
T2DM is characterized by insulin resistance of peripheral
tissues and defective insulin secretion which results from intrinsic
β-cell dysfunction and reduced β-cell mass (Bonner-Weir and
O’Brien, 2008; de Koning et al., 2008). Studies demonstrated a
63% reduction in islet mass of T2DM patients as compared to
normo-glycemic control subjects and a loss of β-cell mass even at
early stages of the disease due to increased rates of apoptosis
(Butler et al., 2003). Both, the peripheral tissues as sites of insulin
action and the site of hormone production itself, the β-cell, are
possible targets for medicinal plant constituents used in the
treatment of T2DM.
Two genera, Dryopteris and Filix, used in Mongolia as medicinal
plants, have been reported to ameliorate diabetic symptoms.
Diabetic rats treated with extracts of these plants showed
improved plasma glucose responses as assessed by oral glucose
tolerance test and decreased glucose clearance rates during low-
dose euglycemic clamp studies were markedly improved by a
single treatment with these extracts. However, insulin levels were
not changed in animals treated with the plant extracts. The
authors concluded that the effect on plasma glucose levels was
due to an improvement in insulin resistance triggered by an
activation of the insulin-signaling pathway in skeletal muscle
and therefore an increased amount of the glucose transporter
GLUT-4 present in the plasma membrane (Khookhor et al., 2007).
Effects on GLUT-4 translocation to the plasma membrane have also
been described for other herbal constituents, such as the stilbe-
noid resveratrol (Penumathsa et al., 2008). On the β-cell level,
marrubiin, an organic extract from Leontis leonurus R.Br, has been
shown to increase insulin secretion in INS-1 cells both at 11.1 mM
and 33.3 mM glucose, and to alleviate diabetic symptoms in a rat
obesity animal model (Mnonopi et al., 2012). Furthermore, nuci-
ferine, the main alkaloid from leaves of Nelumbo nucifera, a plant
used in traditional Vietnamese medicine that exerts anti-diabetic
effects, stimulates insulin secretion in isolated islets from CD1
mouse pancreas and INS-1E cells (Nguyen et al., 2012).
According to the Report of Market Research on Mongolian
Traditional Medicinal Drugs, 2007, Leonurus sibiricus L. (LS) is one
of the most common traditional medicinal raw materials originat-
ing from domestic markets (HSUM and MoH, 2007). It is used to
treat menstrual irregularities, amenorrhea, malaria and hyperten-
sion (Taehakkyo and Yŏn’guso, 1998), and is known for several
beneﬁcial properties, which have been investigated in a number of
scientiﬁc studies. LS was shown to exert anti-inﬂammatory activ-
ity by decreasing levels of inﬂammatory cytokines secreted from
human mast cells (Shin et al., 2009). Moreover, LS can induce
expression of nitric oxide and tumor necrosis factor-α in mouse
peritoneal macrophages (An et al., 2008) and stimulate the murine
uterus in vitro (Shi et al., 1995). Furthermore, it was shown to exert
antibacterial activity (Ahmed et al., 2006), to have analgesic as
well as anti-inﬂammatory activity in rats (Islam et al., 2005), and
to possess potent antioxidant capacity (Lee et al., 2010). In
Mongolian literature, LS is mentioned as a treatment for typical
symptoms of T2DM such as thirst ((Khaidav and Choijamts, 1965)
and personal communication with Prof. Narantuya Samdan,
WHO). It is also used to treat DM in the traditional medicine of
Bangladesh (Mohammed Rahmatullah et al., 2010). As athero-
sclerosis is a well-known diabetic complication, it is of interest
that treatment with a LS herb extract has been shown to affect the
atherogenic process. Thus, C57BL/6 mice on an atherogenic diet
supplemented with a LS herb extract displayed decreased plasma
cholesterol levels, reduced plasma triglyceride levels, and an
increased HDL-cholesterol concentration compared to animals
receiving the atherogenic diet alone (Lee et al., 2010). LS also
leads to a reduction of intracellular reactive oxygen species, which
play an important role in the etiology of atherosclerosis (Singh and
Jialal, 2006). Furthermore, it decreases the expression of adhesion
molecules such as the lectin-like ox-LDL receptor (LOX-1) (Lee et
al., 2010). LOX-1 may mediate the incorporation of ox-LDL into
endothelial cells, a process supposed to promote endothelial
dysfunction, the ﬁrst stage of atherosclerosis (Vita et al., 1990).
Additionally, LOX-1 expression was shown to be elevated in
proatherogenic settings such as T2DM. Through its different effects
on atherosclerosis development, LS may therefore retard the
progression of T2DM and its resulting morbidities.
These observations, as well as the ancient tradition of using LS
to treat the symptoms of DM and DMrD in TMM, led us to
investigate a potential effect of LS on the production site of insulin,
the pancreatic β-cell. Three extracts were monitored: an aqueous
extract (LS OWE), corresponding to the traditional way of admin-
istration, a puriﬁed methanolic extract (LS MeOH/BuOH), and the
water-soluble part of the methanolic extract (MeOH/H2O).
2. Materials and methods
2.1. Plant material
The aerial parts of Leonurus sibiricus were harvested at Tsetser-
leg in the Mongolian province Archangai (latitude 471 280 8.22″;
longitude 1011 260 32.14″) in summer 2009 (collection number 01/
09/mon). The species was identiﬁed by E. Ganbold, Mongolia. A
reference specimen is kept at the herbarium of the School of
Pharmacy, Health Sciences University of Mongolia, Ulaanbaatar,
Mongolia (herbarium number 10080805).
2.2. Preparation of plant extracts
For this study, three different extracts were prepared. As LS is
an ingredient of several traditional prescriptions, which are
usually taken as crude powder together with a glass of water,
we prepared an aqueous crude extract (original water extract, LS
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OWE), which should reﬂect this common administration in tradi-
tional Mongolian medicine. In parallel, an extract was prepared
using methanol as polar organic solvent. The use of methanol
provides enrichment of less polar compounds and a softer hand-
ling during the puriﬁcation process compared to the acidic aqu-
eous solutions (shorter evaporation times, evaporation at lower
temperatures). In order to obtain puriﬁed fractions of high
polarity, the dissolved methanolic extract was partitioned
between solvents of different polarity, yielding the two extracts
used for our analysis, the butanol-soluble extract (LS MeOH/
BuOH), and the water-soluble extract (LS MeOH/H2O).
LS OWE: 5 g powdered dried plant material (drug) were
suspended in 125 mL water, and, after adjustment to pH 2 with
triﬂuoroacetic acid, the suspension was shaken gently at 40 1C for
2 h to simulate gastric conditions. Triﬂuoroacetic acid was used
because it could be removed by vacuum evaporation after extrac-
tion. The extracts were obtained by subsequent freeze-drying. The
yield (2.1 g) is given as drug to extract ratio (DER 2.4:1).
LS MeOH/BuOH and LS MeOH/H2O: 80 g of the powdered plant
material were extracted by accelerated solvent extraction (ASE 200
Accelerated Solvent Extractor, Dionex). Each of the eight extraction
chambers were ﬁlled with 10 g powder and treated with metha-
nol. Each chamber underwent three extraction cycles consisting of
5 min heat up time, 2 min static time, 10% ﬂush volume, and 60 s
nitrogen purge. All resulting solutions were combined and dried
under reduced pressure at 40 1C. The DER of the resulting raw
methanolic extract amounted to 6:1. It was re-dissolved in
methanol and puriﬁed by liquid–liquid extraction using three
solvents of different polarity consecutively. The extraction with
light petroleum was performed to deplete chlorophyll. The
remaining methanolic layer was partitioned against dichloro-
methane followed by water-saturated butanol. The whole proce-
dure resulted in four extracts after evaporation of the solvents
under reduced pressure: the light petroleum extract (DER 23:1),
and the dichloromethane extract (DER 38:1) were not further
investigated; the butanol extract (LS MeOH/BuOH; DER 48:1), and
the aqueous layer which remained after the partition with water
saturated butanol (LS MeOH/H2O; 17:1) were used for the study.
For experiments extracts were dissolved in double distilled water
(LS OWE and LS MeOH/H2O) or methanol (LS MeOH/BuOH) to
receive stock solutions at concentrations of 50 mg/ml (LS OWE and
LS MeOH/H2O) or 500 mg/ml (LS MeOH/BuOH). Respective MeOH-
solvent controls were used for all experimental approaches in
this study.
2.3. Chemicals and reagents
All salts and chemicals used for the preparation of experimen-
tal solutions and cell culture media were p.a. grade.
2.4. Cell culture
INS-1E cells were grown under standard cell culture conditions
(SCC) in RPMI 1640 medium containing 11.1 mM D-glucose, 1 mM
sodium pyruvate, 50 μM β-mercaptoethanol, 2 mM glutamine,
10 mM HEPES, 10% fetal calf serum (FCS), 100 U/mL penicillin,
100 μg/mL streptomycin, and 250 ng/mL amphotericin B at 37 1C,
5% CO2 and 95% air. Subcultures were established twice a week by
trypsin/EDTA treatment. Cells between passages 90 and 110 were
used (Merglen et al., 2004).
2.5. Insulin ELISA
For ELISA experiments, cells were seeded in poly-D-lysine
coated 96-well plates (Sarstedt) at a density of 8,000 cells/well
and grown under standard culture conditions for 48 h prior to the
start of the experiments. To avoid FCS-induced cross-reaction of
serum insulin, experiments were performed in serum-free RPMI
1640 medium. Cells were incubated for 24 h in serum-free
medium containing 500 mg/L LS OWE, LS MeOH/H2O, or MeOH/
BuOH. Untreated and solvent-treated cells served as controls. The
insulin released into the medium during the 24-hour (LS) or 2-
hour (tolbutamide) incubation period was measured using a rat
insulin ELISA kit (Mercodia) according to the manufacturer's
instructions. Subsequently, cell numbers were assessed by using
CellTiter-Glos Luminescent Cell Viability Assay (Promega) (see cell
proliferation assays in this section). Data (ng insulin/mL medium)
were converted to ng insulin/cells in the respective well and
further to ng insulin/100,000 cells.
2.6. Cell membrane potential and intracellular Ca2þ recordings
INS-1E cells were seeded on poly-D-lysine-coated glass cover-
slips and used for patch clamp or Ca2þ imaging after 24–48 h. The
coverslips were transferred to a recording chamber and mounted
on a Nikon TE2000-U inverted microscope. Experiments were
performed at room temperature. The extracellular solution con-
tained (in mM): 135 NaCl, 5.6 KCl, 2.5 CaCl2, 1.5 MgCl2, 10 HEPES-
free acid (FA), 5 glucose, pH 7.4 (adjusted with NaOH), 290 mOsm/
kg. Osmolalities were measured with a vapor pressure osmometer
(Wescor). Solution exchange was performed with a gravity-ﬂow
perfusion system at a ﬂow rate of 1–2 mL/minute. LS OWE
(500 mg/L) and/or tolbutamide (50 or 100 mM) were added to
the extracellular solution as indicated.
Patch clamp recordings were performed in the conventional
whole-cell patch clamp conﬁguration. Patch electrode resistances
were 3–5 MΩ. An EPC-10 ampliﬁer and PatchMaster/FitMaster
software (HEKA) were used for data acquisition and analysis.
Membrane potential recordings were performed in the zero-
current clamp mode. The pipette solution contained (in mM) 130
KCl, 4 MgCl2, 2 CaCl2, 20 HEPES-FA, 10 EGTA. The pH was titrated to
7.2 with KOH (296 mOsm/kg). For voltage clamp recordings of the
KATP conductance an intracellular solution containing (in mM)
4 KCl, 2 MgCl2, 10 HEPES-FA, 10 EGTA, 4 Mg-ATP, 43 mannitol, with
a pH 7.3 (KOH) and 296 mOsm/kg was used. KATP currents were
measured during 500-ms pulses to 80 and 60 mV at 10-s
intervals from a holding potential of 70 mV as previously
described (Hambrock et al., 2007; Jakab et al., 2008). In this range
of potentials the membrane conductance is predominately deter-
mined by KATP currents (Drews et al., 1998).
For monitoring intracellular Ca2þ , cells were loaded with Fluo-
4/AM for 30 min at 37 1C followed by 30 min at room temperature.
The light source equipped with a mercury short arc lamp and an
integrated shutter (LEJ Leistungselektronik Jena GmbH) was
coupled to the microscope (Nikon TE2000-U) via a liquid light
guide. The light was passed through a ﬁlter cube comprising a
340–380 nm excitation ﬁlter, a 440 nm dichroic mirror and a 435–
485 nm emission ﬁlter. 16-bit gray-scale images were captured for
200 ms at 10-second intervals with a cooled CCD camera (Sensi-
Cam, pco). Camera and shutter were controlled by TILLvisION
software, which was also used for analysis. For each experiment,
all cells in the ﬁeld of vision were analyzed (approximately 20
cells). Data are presented as ﬂuorescence intensities obtained from
background-subtracted images.
2.7. RT-PCR of rat insulin receptor
Total RNA was extracted from INS-1E cells using RNAbee
reagent (ams biotechnology) based on phenol/chloroform extrac-
tion and isopropanol precipitation according to the manufacturer's
recommendations. 1 mg of isolated RNA was used for the reverse
transcriptase (RT) reaction with oligo-dT18 primers performed
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with the ﬁrst strand cDNA synthesis kit (Fermentas). mRNA levels
of rat insulin receptor were determined by PCR (35 cycles,
annealing temperature 61 1C) using speciﬁc primers (GenBank
accession # NM_017071.2; forward: 50-CATGAATTCCAGCAACTT-
GATGTGC-30, reverse: 50-CAGGTTGTTGCCCCCTCGGATGT-30), yield-
ing a 172-bp fragment. PCR products were separated on a 1.5%
agarose gel and visualized by ethidium bromide staining.
2.8. Cell proliferation assays
For the assessment of the effect of LS extracts on cell prolifera-
tion, INS-1E cells were seeded in poly-D-lysine-coated standard
96-well plates at a density of 8000 cells/well. Cells were grown for
48 h before incubation with LS extracts for further 24 and 48 h,
respectively. Cell numbers were assessed by using CellTiter-Glos
Luminescent Cell Viability Assay (Promega) following the manu-
facturer's instructions at three different time points, i.e. at time
point zero (the time point of the addition of the LS-extracts to the
cells), as well as 24 and 48 h after addition of LS-extracts. The cell
numbers at the time point zero were set to 100% and the cell
numbers assessed at the other two time points were normalized to
these values.
2.9. LC-MS analyses
HPLC-ESI-MSn analyses were performed on an UltiMate 3000
RSLC-series system (Dionex, Germering, Germany) coupled to a 3D
quadrupole ion trap mass spectrometer equipped with an ortho-
gonal ESI source (HCT, Bruker Daltonics, Bremen, Germany). HPLC
separation was carried out on a LiChrospher 100 RP18e column,
4.6250 mm, 5 mm (Agilent, CA, USA) at 25 1C using water (pH
2.8 with formic acid) and methanol as mobile phase A and B,
respectively. The ﬂow rate was 1.0 mL/min and the following
gradient program was used for the LS OWE sample: 10% B
(0 min), 50% B (80 min), and 95% B (81 min). The gradient program
for the LS MeOH/BuOH sample was as follows: 10% B (0 min), 30%
B (20 min), 30% B (42 min), 50% B (82 min), and 95% B (83 min). UV
data were recorded from 190 to 400 nm. The eluent ﬂow was split
roughly 1:8 before the ESI ion source, which was operated slightly
different for the LS OWE sample (capillary voltage:73.7 kV,
nebulizer: 32 psi (N2), dry gas ﬂow: 9 L/min (N2), and dry tem-
perature: 350 1C) and for the LS MeOH/BuOH sample (capillary
voltage: þ3.7/4.0 kV, nebulizer: 22 psi (N2), dry gas ﬂow: 8 L/
min (N2), and dry temperature: 320 1C). The mass spectrometer
was operated in an automated data-dependent acquisition (DDA)
mode to obtain MS2 and MS3 spectra (collision gas: He, isolation
window: 4 Th, fragmentation amplitude: 1.0 V). The aglycone part
of the ﬂavonoids was identiﬁed by spectrum matching to an in-
house library containing the MSn spectra of 57 reference ﬂavo-
noids using ESI compass 1.3 for HCT (Bruker Daltonics).
2.10. HPLC-UV-DAD analyses
HPLC-UV-DAD analyses were performed on a Prominence LC-
20AD coupled to a Prominence SPD-M20 Diode Array Detector
(Shimadzu Corporation, Kyoto, Japan) and to a low temperature-
evaporative light scattering detector (ELSD-LT, Shimadzu Corpora-
tion, Kyoto, Japan). The chromatographic system was identical to
the one employed for the MS analyses. For the sample solution of
the LS OWE 25 mg were dissolved in 100 mL aqueous methanol,
10 mL thereof were injected. For the sample solution of the LS
MeOH/BuOH 1.0 mg of the MeOH/BuOH extract were dissolved in
100 mL methanol, 5 mL thereof were injected. The temperature of
the ELSD was set to 40 1C at an air pressure of 360 kPa.
2.11. Statistics and data presentation
Data are expressed as mean7SEM. Statistical analysis was
carried out using unpaired or paired Student's t-test or the general
linear model with one ﬁxed and one random effect, as applicable.
P valueso0.05 between groups were considered as statistically
signiﬁcant. Data were analyzed and plotted using GraphPad Prism
version 5.0d for PC (GraphPad Software).
3. Results
3.1. Effects of Leonurus sibiricus extracts on insulin release under
standard cell culture conditions (SCC)
To determine the effect of extracts from LS on the amount of
insulin released from rat INS-1E cells, insulin levels were deter-
mined by ELISA. Insulin released into the culture medium under
SCC, i.e. in the presence of 11.1 mM glucose, over 24 hours was
signiﬁcantly increased in presence of 500 mg/L LS OWE as well as
LS MeOH/H2O from 19.577.0 ng to 30.377.7 ng and 33.177.5 ng
per 100,000 cells (n¼5), respectively (Fig. 1). No effect was
observed at concentrations of 100 mg/L. In contrast, in a separate
series of experiments, exposure to 100 mM tolbutamide (a con-
centration twice as high as necessary to elicit a maximum
electrophysiological response in our experiments; see Fig. 2),
which is known to enhance insulin secretion in INS-1E cells kept
at 2.5 or 3.3 mM glucose, respectively (Merglen et al., 2004;
Taguchi et al., 2008), did not signiﬁcantly enhance insulin secre-
tion from 15.877.0 to 19.079.5 ng insulin/100,000 cells under
SCC conditions within 2 h (n¼6; p¼0.27).
3.2. Effects of Leonurus sibiricus extracts on INS-1E single cell
electrical activity
To investigate if the increased insulin secretion induced by LS
was due to stimulation of electrical activity, we performed whole-
cell patch clamp recordings of the cell membrane potential (Vmem).
As shown in ﬁg. 2B, LS OWE (500 mg/L) acutely and signiﬁcantly
depolarized INS-1E cells from 61.571.5 mV to 31.371.4 mV
within 1.5 min (n¼4). In one out of ﬁve experiments LS OWE
was without effect. Fig. 2A shows a recording of a spontaneously
Fig. 1. Levels of insulin released from INS-1E insulinoma cells during 24 h of
culture with LS extracts (500 mg/L) measured by ELISA. A statistically signiﬁcant
difference is evident in cells treated with 500 mg/L LS OWE as well as with LS
MeOH/H2O (n¼5), compared to basal secretion in untreated cells, whereas the
MeOH/BuOH extract is without effect, compared to its MeOH-solvent control
(*po0.05; ns, not signiﬁcant; unpaired t-test).
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active cell before the application of LS OWE; tracing 1 depicts the
electrical activity recorded under control conditions. Along with
depolarizing the cell, LS OWE caused an initial increase and a
subsequent decline of action potential (AP) frequency with per-
sisting depolarization, whereby the AP amplitude gradually
decreased (tracings 2 and 3). The LS OWE-induced depolarization
was fully reversible (Fig. 2B); Vmem after wash-out of LS OWE was
66.074.3 mV (n¼4). Spontaneous electrical activity, however,
did not recur. Subsequent application of the sulfonylurea tolbuta-
mide (100 mM) rapidly depolarized Vmem to 14.573.1 mV (n¼4)
with low amplitude APs similar to those observed during LS OWE
application (Fig. 2A, tracing 4). Tolbutamide was signiﬁcantly more
effective in depolarizing Vmem than LS OWE. LS OWE (500 mg/L)
applied on top of tolbutamide did not add to the effect of the
sulfonylurea (17.575.1 mV; n¼3; Fig. 2B).
The apparent resemblance of the LS OWE effect to the effect of
tolbutamide led us to test if the herb extract might likewise act on
the ATP-sensitive Kþ conductance (IKATP). After establishing the
whole-cell patch clamp conﬁguration, Vmem was clamped to
70 mV and voltage pulses to 80 and 60 mV with durations
of 500-ms were applied every 15 s. In this range of potentials, the
whole-cell conductance of β-cells is mainly determined by IKATP
(Drews et al., 1998). Clamping the intracellular ATP concentration
by dialyzing the cytoplasm with the pipette solution yielded stable
control currents within 2–5 min (Fig. 3). Similar to tolbutamide
(50 mM), LS OWE (500 mg/L) brought a signiﬁcant and reversible
inhibition of the KATP current, reaching a plateau after 1–2 min. An
inhibitory effect of LS was observed in 3 out of 5 experiments.
Exemplary time courses and current tracings are shown in Figs. 3A
and B for LS and Figs. 3C and D for tolbutamide. LS OWE caused an
inhibition to 62.078.5% and 57.777.4% of control currents at 80
and 60 mV, respectively (Fig. 3E). Tolbutamide (50 mM) reduced
IKATP to 34.777.5% (at 80 mV) and 31.774.3% (at 60 mV) of
control values. The inhibition by tolbutamide measured at -60 mV
was signiﬁcantly stronger compared to LS OWE.
3.3. Effect of Leonurus sibiricus extracts on intracellular Ca2þ (Cai)
To assess whether the altered electrical behavior of INS-1E cells
under LS OWE is paralleled by a rise in Cai, cells were loaded with
the Ca2þ sensitive ﬂuorescent dye Fluo-4/AM and acutely super-
fused with extracellular solution containing LS OWE (500 mg/L),
tolbutamide (100 mM) and LS OWE plus tolbutamide. On average,
LS OWE and tolbutamide led to a reversible rise of Cai up to
30710% and 68714% (n¼3) compared to control conditions,
respectively (Fig. 4B), with a high variability of single cell
responses (Fig. 4A). Peak responses were followed by a decline
of the signal in the persisting presence of drugs. In two out of
Fig. 2. LS OWE reversibly depolarizes INS-1E cells. (A) Whole-cell zero-current clamp recording in absence and presence of LS OWE (500 mg/L), during wash-out of the
extract followed by the application of tolbutamide (TOL, 100 mM), LS OWE on top of TOL and ﬁnal wash-out of both substances. 1–4 show 15-second segments of the upper
recording on an expanded time scale before (1), during application of LS OWE (2, 3) and tolbutamide (4), as indicated in (A). (B) Summary of patch clamp data (n¼3,
mean7SEM; 1way ANOVA with Bonferroni's multiple comparison post-test; *po0.05; ns, not signiﬁcant).
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Fig. 3. Inhibition of the ATP-sensitive Kþ current (IKATP) in INS-1E cells by LS OWE (whole-cell patch clamp recordings). Voltage pulses to 80 and 60 mV with durations
of 500-ms were applied every 15-seconds from a holding potential of 70 mV (insert). (AþC) IKATP recorded in the absence and presence of LS OWE (500 mg/L) or
tolbutamide (TOL, 50 mM). Each data point represents the average current during a 500-ms voltage pulse. Tracings were zero-offset subtracted so that currents recorded at
80 and 60 mV appear as negative and positive deﬂections, respectively. (BþD) Corresponding original current tracings at the time-points a (control), b (presence of LS
OWE or TOL) and c (wash-out) as indicated in AþC. (E) Scatter blot summarizing the results of 3 individual experiments. Data are shown as % of control currents. *po0.05
(unpaired t-tests).
Fig. 4. LS OWE induces an acute and reversible rise in intracellular Ca2þ (Cai). Cells were loaded with Fluo-4/AM and the ﬂuorescence intensity was measured in the absence
or presence of drugs as indicated (500 mg/L LS OWE; 100 mM tolbutamide, TOL). Images were acquired at 10-s intervals. (A) Responses of single cells (gray tracings) and
mean response of all 20 cells in the ﬁeld of view (black tracing) of an individual experiment. (B) Bar graph showing the average of the mean responses of 3 individual
experiments (LS OWE and TOL, n¼3; paired t-test; TOLþLS OWE, n¼2; *po0.05). Data are given as % change in ﬂuorescence intensity compared to control conditions.
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three experiments we applied LS OWE on top of tolbutamide, as
shown in Fig. 4A, and observed that LS OWE could elicit a further
Ca2þ peak. However, similar to the observation concerning Vmem
recordings, there was no additive effect to the overall response of
tolbutamide alone.
3.4. Insulin-receptor expression
To verify the expression of the insulin-receptor (IR) in INS-1E
cells, which is the prerequisite for an auto/paracrine effect of the
hormone, we performed RT-PCR. As shown in Fig. 5 the expected
amplicon (172-bp fragment) can be detected using primers speciﬁc
for the rat IR α-subunit.
3.5. Inﬂuence of Leonurus sibiricus extracts on cell proliferation
Insulin acts as a growth factor in β-cells. Given the expression
of insulin-receptors in INS-1E cells, an altered proliferative beha-
vior of INS-1E cells, caused by the increased amounts of insulin
secreted from the cells due to LS treatment, is plausible. We
therefore assessed the effect of the three LS extracts, OWE, MeOH/
H2O and MeOH/BuOH (500 mg/L each) on cell proliferation 24 and
48 h after treatment. The data are shown in Fig. 6. All extracts
signiﬁcantly increased the number of cells compared to untreated
cells or the respective methanol control (0.1%). After 24 h, LS OWE
increased the number of cells to 173710%, LS MeOH/H2O to
17379% compared to 14974% of untreated cells, while LS
MeOH/BuOH had no signiﬁcant effect (176711%) compared to
the 0.1% methanol-control (152.572.6%). After 48 h, LS OWE
caused an increase in cell number to 215.475.2%, LS MeOH/H2O
to 218.9 77.1% compared to untreated cells (189.171.9%). LS
MeOH/BuOH also enhanced cell proliferation compared to the
control (223.877.5% vs. 194.172.3%).
3.6. Phytochemical characterization of the of Leonurus sibiricus
plant extracts
The main phenolic constituents in the LS MeOH/BuOH extract
were identiﬁed as chlorogenic acid, ﬂavonoid glycosides and most
prominently glycosylated phenyl ethanoids such as verbascoside
and lavandulifolioside by LC-MS (see structural formulae, Fig. 7,
and Table 1). These typical phenyl ethanoids were not detected in
the LS OWE. The latter was characterized by a high content of
stachydrine, which was identiﬁed by LC-MS and conﬁrmed by TLC
analysis comparing the Rf values with a reference compound after
detection with Dragendorff reagent. After depletion of stachydrine,
Fig. 5. Expression of the insulin-receptor (IR) in INS-1E cells. The sample contain-
ing cDNA template (þ) yields a speciﬁc ampliﬁcation product for the IR α-subunit
(172 bp). NTC, non-template control; M, 50-bp DNA size marker. (1.5% agarose gel,
ethidium bromide staining).
Fig. 6. Increased proliferation rates of INS-1E cells treated with LS OWE, MeOH/H2O and MeOH/BuOH (500 mg/L) after 24 (A) and 48 (B) hours. * Statistically signiﬁcant
difference compared to control conditions (po0.05, Mann-Whitney test or unpaired t-test with Welch's correction).
Fig. 7. HPLC chromatogram of the LS MeOH/BuOH extract showing the DAD
response at 30072 nm. The extract was also analyzed by LC-MS and the proposed
structures of corresponding compounds 1–11 can be found in Table 1.
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quercetin glycosides and derivatives of phenolic carbonic acids
were found as minor phenolic components of the LS OWE (data
not shown).
As stachydrine was found to be present in LS OWE in high
amounts, we tested whether stachydrine alone was the active
compound accounting for the augmented insulin secretion from LS
OWE-treated INS-1E cells. However, the sole application of stachy-
drine had no effect on insulin secretion in this cell line (3
individual experiments, data not shown).
4. Discussion
In the present study we determined whether extracts from
Leonurus sibiricus L., a plant used in the treatment of DM and/or
DMrD in TMM, affect pancreatic β-cell function. We have chosen
rat INS-1E cells as a T2DM cell culture surrogate, as these cells are
maintained at 11.1 mM glucose as standard cell culture condition
(SCC), thus mimicking a hyperglycemic metabolic situation. If pre-
incubated at glucose concentrations of 2.5 mM, these cells exhibit
a dose-dependent glucose-induced insulin release with a plateau
phase at 15–20 mM and a 50% effective concentration at 10.4 mM
(Merglen et al., 2004), which is close to the SCC glucose concen-
tration of 11.1 mM as used in this study. Therefore the experi-
mental conditions chosen still allow for the detection of at least a
shallow elevation of insulin release, while simultaneously simulat-
ing T2DM conditions. While under these conditions 100 mM
tolbutamide had no stimulatory effect on insulin release within
2 h of treatment, exposure of the cells to aqueous extracts from LS
for 24 h resulted in an increased secretion. This effect was
observed for OWE and MeOH/H2O extracts, whereas the MeOH/
BuOH extract showed no effect (Fig. 1). This suggests that the
active compound(s) in LS responsible for the stimulation of insulin
secretion is/are very polar and highly soluble in water. According
to the conventional stimulus-secretion-coupling model insulin
secretion is driven by elevated concentrations of plasma glucose
and other physiological secretagogues like amino acids, triglycer-
ols and free fatty acids. Glucose uptake and metabolism results in
an increased ATP/ADP ratio thereby closing of ATP-sensitive Kþ
(KATP; KIR 6.2/ SUR1) channels, depolarization of the cell mem-
brane potential (Vmem) and stimulation of insulin exocytosis by
Ca2þ inﬂux through voltage-dependent Ca2þ channels (Ashcroft
et al., 1989; Henquin, 2000; Satin et al., 1995). In adherence to that
model, we tested the effect of LS OWE on the electrical behavior of
INS-1E cells. Acute application of LS OWE resulted in closure of
KATP channels, and depolarization of Vmem, which was paralleled
by an initial increase and subsequent decline of action potential
(AP) frequency with persisting Vmem depolarization, gradually
decreasing amplitudes and silencing of the APs. Washout of LS
OWE caused a repolarization of Vmem without spontaneous elec-
trical activity. Subsequent application of tolbutamide elicited a
depolarization with low amplitude APs similar to those observed
during application of LS OWE. This behavior was not further
modiﬁed upon additional application of LS OWE (Fig. 2). LS
OWE- and tolbutamide-induced depolarizations of Vm were par-
alleled by an increase in Cai (Fig. 4), most likely reﬂecting the
opening of voltage-activated Ca2þ channels. In further experi-
ments we could show that, similar to tolbutamide, LS OWE inhibits
KATP channels (Fig. 3). In a previous study on the effect of the
phytostilbene resveratrol on the electrophysiological and secretory
behavior of INS-1E cells, we found that the compound inhibits KATP
channels (IKATP), L- and T-type voltage-dependent Ca2þ channels
and swelling-activated Cl currents (IClislet, IClglucose, IClswell)
(Jakab et al., 2008). Even though both, hyperpolarizing IKATP as
well as depolarizing Ca2þ- and Cl currents, were inhibited by
resveratrol, the net effect was an inhibition of electrical activity
(APs) and insulin release. Since LS OWE represents a mixture of
compounds, it is likely that it exerts multiple effects on different
ion conductances – probably with different temporal and dose-
response proﬁles. The net effect of LS OWE is a depolarization and
stimulated insulin release, for which the block of KATP channels
provides a plausible explanation. However, we cannot exclude that
the effect of LS on Vmem and Cai are due to additional effects on
other ion conductances (e.g., inhibition of further Kþ currents, or
activation of depolarizing ion conductance(s) like Ca2þ- or Cl
channels, or a combination thereof). It has previously been shown
Table 1
Proposed structure and MS data of the secondary plant metabolites identiﬁed in the LS MeOH/BuOH extract.
# Proposed structurea [M-H]- Main fragment ions (410% Rel. Int.) References
1 Chlorogenic acid 353.1 MS2 [353.1]: 190.8 Ritter et al. (2010)
2 Quercetin-O-hexosyl hexosideb 625.2 MS2 [625.2]: 445.1, 300.9, 299.9, 270.9, 254.9
MS3 [299.9]: 270.9, 254.8, 178.7, 150.7
–
3 Lavandulifoliosidec 755.3 MS2 [755.3]: 623.2, 593.3, 461.1 MS3 [593.3]: 461.2
MS3 [461.1]: 315.0, 314.1, 178.8, 160.8, 144.8, 135.9, 134.9,
133.9
Krasteva et al. (2011) and Ritter et al. (2010)
4 Verbascosidec 623.2 MS2 [623.2]: 461.2 MS3 [461.2]: 315.0, 160.8, 134.9 Li et al. (2012) and Ritter et al. (2010)
5 Lavandulifolioside-isomer 755.3 MS2 [755.3]: 623.2, 593.3, 461.2 MS3 [593.3]: 461.2
MS3 [461.2]: 315.0, 297.0, 160.8, 135.9, 134.8
Cai et al. (2005)
6 Leonoside A 769.3 MS2 [769.3]: 637.3, 607.2, 593.3, 461.2 MS3 [637.3]: 491.1,
461.2
MS3 [593.3]: 461.2
Calis et al. (1992)
7 Quercetin-O-deoxyhexosyl
hexosideb
609.2 MS2 [609.2]: 300.9, 300.0, 270.9
MS3 [300.9]: 272.9, 270.9, 254.8, 178.8, 150.7
Fernando Rolim de Almeida et al. (2008) and Hayashi et al.
(2001)
8 Verbascoside-isomer 623.2 MS2 [623.2]: 461.1 MS3 [461.1]: 315.0, 160.8, 134.9 –
9 Leucoceptoside A 637.3 MS2 [637.3]: 461.1 MS3 [461.2]: 315.0, 297.0, 160.8, 142.8,
134.9
Tasdemir et al. (1999)
10 Leonoside A-isomer 769.3 MS2 [769.3]: 637.3, 593.3, 461.1 MS3 [637.3]: 491.1, 461.2
MS3 [593.3]: 461.1
–
11 Leonoside B 783.3 MS2 [783.3]: 651.3, 607.3
MS3 [607.3]: 475.2
Calis et al. (1992)
a The identiﬁcation of the compounds is based either on direct comparison of the experimental MS data with literature data or on congruence of the MS- and UV-data
with the structure of known secondary metabolites from Leonurus sibiricus or other Leonurus species.
b The aglycone part of the ﬂavonoids as identiﬁed by spectrum matching to an in-house library containing the MSn spectra of 57 reference ﬂavonoids using ESI compass
1.3 for HCT (Bruker Daltonics, Bremen, Germany).
c These constituents were conﬁrmed by comparison of the retention times and UV-spectra with reference compounds.
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that aqueous extracts from Leonurus cardiaca, another species of
the genus Leonurus used to treat tachyarrhythmia and other
cardiac disorders, act as a mixed inhibitor of ICa.L- and IKr-
channels as well as a modulator of If- channels (Ritter et al.,
2010). The natural polyphenolic ﬂavenoid quercetin has recently
been found to stimulate insulin secretion in INS-1 cells and rat
isolated pancreatic islets by direct activation of L-type calcium
channels (Bardy et al., 2013). Since quercetin-O-hexosyl hexoside
and quercetin-O-deoxyhexosyl hexoside are consitutents of the LS
extract (Table 1 and Fig. 7), it may be assumed that the observed
effects of LS on insulin secretion/proliferation may at least in part
arise from a comparable effect. In mouse pancreatic islet cells the
mitochondrial uncoupling protein 2 (UCP2) could be identiﬁed as a
target of genipin, a compound found in Gardenia jasminoides Ellis
fruits, which is used in traditional Chinese medicine to treat T2DM
symptoms; the substance was shown to inhibit UCP2, to increase
mitochondrial membrane potential and ATP levels, to inhibit KATP
channels and to stimulate insulin secretion (Zhang et al., 2006).
Besides its metabolic action on peripheral tissues, insulin also
acts in an auto/paracrine manner as e.g. shown in MIN6 cells
(Muller et al., 2006), which is important for cell proliferation and
survival and hence the maintenance of the β-cell mass of pan-
creatic islets. Recent studies have further concluded that insulin is
a positive regulator of its own production (Leibiger et al., 1998; Xu
et al., 2000) and β-cell-speciﬁc insulin receptor (IR) knockout mice
manifest reduced islet size, progressive glucose intolerance, as
well as reduced insulin content (Kulkarni et al., 1999). In the
current study, we show that LS extracts stimulate INS-1E cell
proliferation. Since we also demonstrate the presence of the IR in
INS-1E cells, the LS-boosted proliferation rates may be explained
by such an auto/paracrine action of the hormone. Moreover, it
cannot be excluded that LS constituents have a direct effect on cell
proliferation. With respect to that it is noteworthy to mention that
not only LS OWE and LS MeOH, but also LS MeBuOH was able to
stimulate INS-1E cell proliferation (Fig. 6) despite its inability to
increase insulin secretion (Fig. 1). Clearly the cellular signaling
pathways mediating the proliferative effects of LS extracts need to
be identiﬁed in further studies.
In conclusion we show that extracts from Leonurus sibiricus
increase insulin secretion of rat INS-1E insulinoma cells that can
be explained at least in part by a transiently increased electrical
activity and elevation of the intracellular calcium concentration.
Moreover, treatment with LS extracts stimulates INS 1-E cell
proliferation. These ﬁndings may provide explanations for the
empirical use of LS formulations in the treatment of diabetes
mellitus and its related disorders in traditional medicine.
Structural formulae
Verbascoside¼Acteoside (R1–R5¼H)
Lavandulifolioside (R1, R2, R3, R4¼H; R5¼arabinose)
Leucosceptoside A (R1, R2, R4, R5¼H; R3¼Me)
Leonoside A (R1, R2, R4¼H; R3¼Me; R5¼arabinose)
Leonoside B (R1, R3¼Me; R2, R4¼H; R5¼arabinose)
Stachydrine
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